Addex Therapeutics Ltd (ADXN) Volatility Skew

Implied volatility skew shows how IV varies across strike prices for a given expiration. Steeper skews indicate higher demand for downside protection relative to upside speculation.

Addex Therapeutics Ltd (ADXN) operates in the Healthcare sector, specifically the Biotechnology industry, with a market capitalization near $7.1M, listed on NASDAQ, employing roughly 3 people, carrying a beta of 2.00 to the broader market. Addex Therapeutics Ltd, a biopharmaceutical firm in a developmental phase, operates out of Switzerland, focusing on the discovery, advancement, and commercialization of small-molecule drugs targeting central nervous system (CNS) disorders. Led by Timothy Mark Dyer, public since 2020-02-12.

Volatility skew analysis compares implied volatility across strikes and expirations. No recent options activity for ADXN as of 2026-08-23; this typically reflects low options liquidity, a recently listed name, or a temporary data feed delay. Snapshot will refresh on the next active session.

Learn how volatility skew is reported and how to read the data →